Phase I/II results of RTOG L-0117; a phase I/II dose intensification study using 3DCRT and concurrent chemotherapy for patients with inoperable NSCLC

被引：2

作者：

Bradley, Jeffrey D.

Graham, Mary V.

Moughan, Jennifer

Byhardt, Roger

Govindan, Ramaswamy

Fowler, Jack

Purdy, James

Michalski, Jeff M.

Gore, Elizabeth

Choy, Hak

机构：

[1] Washington Univ, Sch Med, St Louis, MO USA

[2] Phelps Cty Reg Med Ctr, Rolla, MO USA

[3] RTOG Headquarters, Philadelphia, PA USA

[4] Med Coll Wisconsin, Milwaukee, WI 53226 USA

[5] Univ Wisconsin, Madison, WI USA

[6] Univ Calif Davis, Davis, CA 95616 USA

[7] Univ Texas SW, Dallas, TX USA

来源：

关键词：

D O I：

10.1097/01.JTO.0000283430.04886.de

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S476 / S476

页数：1